AgeX Therapeutics, Inc. AGE NYSE

NYSE • Healthcare • Biotechnology • US • USD

SharesGrow Score

24/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

AgeX Therapeutics, Inc. (AGE) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 BHVN, CVKD, FHTX, GRPH, ICCC, ICVX 等.

AGE 的市值为 $27.76M, 而同行平均市值为 $561.83M. AGE 显著小于其平均同行.

同行与相似公司 — AGE

Cadrenal Therapeutics, Inc. Common Stock

$4.81 +0.42% $12.06M

FHTX

Foghorn Therapeutics Inc.

$4.87 +0.41% $285.87M

GRPH

Graphite Bio, Inc.

$3.18 -2.75% $185.19M

$15.31 -0.91% $769.04M

Inhibrx Biosciences, Inc.

$83.60 +0.49% $1.22B

IVVD

Invivyd, Inc.

$1.71 +6.21% $226.97M

LCTX

Lineage Cell Therapeutics, Inc.

$1.63 +2.52% $406.01M

LRMR

Larimar Therapeutics, Inc.

$4.83 -0.82% $413.34M

LYRA

Lyra Therapeutics, Inc.

$0.44 -11.98% $781.13K

其他人也在看

PRAX

Praxis Precision Medicines, Inc.

Oxford Nanopore Technologies plc

$1.53

+1.41%

INBX

Inhibrx Biosciences, Inc.

Larimar Therapeutics, Inc.

$4.83

-0.82%

LCTX

Lineage Cell Therapeutics, Inc.

$1.63

+2.52%

AgeX Therapeutics, Inc. AGE NYSE

同行与相似公司 — AGE

其他人也在看

获取低估股票提醒